Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,138.00    -16.00 (-0.74%)
Bid:
2,136.00
Ask:
2,138.00
Spread: 2.00 (0.094%)
Market Cap: £3.59b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Johnson Matthey announces new hydrogen gigafactory

18 Jul 2022 07:00

RNS Number : 7198S
Johnson Matthey PLC
18 July 2022
 

Johnson Matthey announces new hydrogen gigafactory to accelerate the transition to a decarbonised transport economy

18 July 2022

 

 

· JM invests in capacity to support customer growth, backed by customer demand

· UK government through the Automotive Transformation Fund and Advanced Propulsion Centre (APC) today announce their support for JM's hydrogen gigafactory

 

Johnson Matthey (JM), a global leader in sustainable technologies, announces that it is building an £80 million gigafactory at its existing site in Royston, UK, to scale up the manufacture of hydrogen fuel cell components. Earlier this year, JM announced a refreshed strategy, with an ambition to be the "market leader in performance components for fuel cells and electrolysers", targeting more than £200 million sales in Hydrogen Technologies by end of 2024/25.

The gigafactory will initially be capable of manufacturing 3GW of proton exchange membrane (PEM) fuel cell components annually for hydrogen vehicles and is supported by the UK Government through the Automotive Transformation Fund (ATF). The APC forecasts that the UK will need 14GW of fuel cell stack production and 400,000 high pressure carbon fibre tanks annually to meet local vehicle production demands by 2035 whilst the market expects that there could be as many as three million fuel cell electric vehicles (FCEVs) on the road globally by 2030.

The investment will safeguard highly skilled manufacturing jobs in the UK. The site is expected to be in operation by H1, 2024.

The new facility at Royston will deploy state-of-the-art manufacturing processes to scale up production of fuel cell components and to meet customer demand. The site could be expanded in the future, almost tripling potential capacity by using the decommissioned Clean Air production facility, to produce both fuel cell and green hydrogen components.

Liam Condon, Chief Executive of Johnson Matthey said: "Decarbonising freight transportation is critical to help societies and industries meet their ambitious net zero emission targets - fuel cells will be a crucial part of the energy transition. For more than two decades, JM has been at the forefront of fuel cell innovation. The fuel cell market has now reached a pivotal moment with the increasing urgency to decarbonise transportation and today marks the next step of the journey to a low-carbon future in the UK. We're delighted to be playing a key role in driving it forward."

Business Secretary Kwasi Kwarteng: "This investment, backed by Government, is a major vote of confidence from Johnson Matthey in the UK. Their new facility will not only add to our growing electric vehicle supply chain, but it will also help secure hundreds of highly skilled jobs.

 "We are working hard to ensure the UK reaps the benefits of the green industrial revolution, and today's announcement reaffirms UK's reputation as one of the best locations in the world for high quality auto manufacturing."

Ian Constance, Chief Executive of the APC, the organisation tasked by the automotive industry and government to accelerate development of green vehicle technology and responsible for managing ATF, said: "This is incredibly significant and puts the UK in an enviable position in the global fuel cell supply chain. Our insight forecasts that the UK could dominate European fuel cell production and be a centre of excellence globally and today's announcement is a huge step towards realising that ambition.

"We already have 15% of the fuel cell value chain radiating from UK businesses but this could be as much as 65% just by expanding on current strengths in electrochemistry and coatings or using our automotive capability to volume manufacture components. Johnson Matthey, a world-leader in hydrogen technology, have seen this opportunity and I'm delighted they have chosen the UK to grow this capability."

Road freight accounts for about 9% of global CO2 emissions, with 62% arising from medium and heavy-duty trucking - the hardest-to-abate transport segments. Hydrogen fuel cell electric vehicles (FCEV) provide similar benefits to existing technology such as fast refuelling and long range but emit zero kerbside CO2 or other pollutants, so they are a popular option for decarbonising heavy-duty commercial vehicles and are core to a net zero future.

 

 

ENDS

Johnson Matthey is a global leader in sustainable technologies that enable a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, energy, chemical processing and making the most efficient use of the planet's natural resources. Today about 15,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit www.matthey.com

Inspiring science, enhancing life

 

For further information, please contact

 

Surinder Sian / Barney Wyld

0207 269 8001

jmpr@matthey.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREANXSFSKAEFA
Date   Source Headline
11th Jun 202612:17 pmRNSDirector/PDMR Shareholding
10th Jun 202610:00 amRNSAnnual Financial Report
3rd Jun 20269:03 amRNSDirector/PDMR Shareholding
2nd Jun 20264:40 pmRNSDirector/PDMR Shareholding
1st Jun 20264:02 pmRNSHolding(s) in Company
28th May 20267:05 amRNSBoard Changes
28th May 20267:01 amRNSJohnson Matthey acquisition of Cormetech
28th May 20267:00 amRNSJohnson Matthey Full Year Results
14th May 202611:42 amRNSDirector/PDMR Shareholding
16th Apr 202611:51 amRNSDirector/PDMR Shareholding
24th Mar 202611:30 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSDirector Declaration
24th Feb 20263:30 pmRNSDirector/PDMR Shareholding
24th Feb 20269:48 amRNSDirector/PDMR Shareholding
23rd Feb 20265:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20267:00 amRNSUpdate on Catalyst Technologies sale
12th Feb 202612:44 pmRNSDirector/PDMR Shareholding
14th Jan 20262:22 pmRNSDirector/PDMR Shareholding
8th Jan 202610:01 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20254:51 pmRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSDirectorate change
20th Nov 20257:00 amRNSJohnson Matthey Half Year Results
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
24th Oct 202511:29 amRNSHolding(s) in Company
21st Oct 20253:44 pmRNSHolding(s) in Company
13th Oct 202511:55 amRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSFinancial reporting structure and trading update
3rd Oct 202510:23 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSHolding(s) in Company
26th Sep 20255:29 pmRNSHolding(s) in Company
17th Sep 20259:00 amRNSDirector Declaration
15th Sep 20252:37 pmRNSHolding(s) in Company
11th Sep 20254:13 pmRNSDirector/PDMR Shareholding
8th Sep 20256:00 pmRNSHolding(s) in Company
4th Sep 20255:19 pmRNSHolding(s) in Company
2nd Sep 20254:07 pmRNSHolding(s) in Company
29th Aug 202512:05 pmRNSTotal Voting Rights
26th Aug 20252:07 pmRNSDirector/PDMR Shareholding
13th Aug 20254:38 pmRNSDirector/PDMR Shareholding
13th Aug 20251:51 pmRNSDirector/PDMR Shareholding
5th Aug 20255:19 pmRNSHolding(s) in Company
5th Aug 20254:50 pmRNSDirector/PDMR Shareholding
25th Jul 20252:12 pmRNSHolding(s) in Company
23rd Jul 20252:23 pmRNSHolding(s) in Company
18th Jul 202512:07 pmRNSDirector/PDMR Shareholding
18th Jul 20259:18 amRNSHolding(s) in Company
17th Jul 20252:20 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.